Skip to content
Prosidion

Prosidion Ltd.

Biochemical Cell Research and Diabetes

Menu
  • Home
  • protein
  • DNA
  • LDHB Rabbit Polyclonal Antibody
  • Distributors
  • Contact Us
Menu
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis

Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis

Posted on September 12, 2021July 24, 2021 by Andres
Coronavirus illness 2019 (COVID-19) is an infectious illness precipitated by the newly found coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been noticed in sufferers with diabetes mellitus (DM). This research aimed to determine common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have built-in human whole-genome transcriptomic datasets from COVID-19 and DM, adopted by practical evaluation with gene ontology (GO) and pathway analyses.
In peripheral blood mononuclear cells (PBMCs), among the many upregulated differentially expressed genes (DEGs), 32 had been discovered to be generally modulated in COVID-19 and sort 2 diabetes (T2D), whereas 10 DEGs had been generally downregulated. As regards sort 1 diabetes (T1D), 21 DEGs had been generally upregulated, and 29 DEGs had been generally downregulated in COVID-19 and T1D. Moreover, 35 DEGs had been generally upregulated in SARS-CoV-2 contaminated pancreas organoids and T2D islets, whereas 14 had been generally downregulated.
Several GO phrases had been present in common between COVID-19 and DM. Prediction of the putative transcription components concerned within the upregulation of genes in COVID-19 and DM recognized RELA to be implicated in each PBMCs and pancreas. Here, for the primary time, we have now characterised the organic processes and pathways generally dysregulated in COVID-19 and DM, which might be within the subsequent future used for the design of customized remedy of COVID-19 sufferers affected by DM as comorbidity.

Cisplatin’s potential for sort 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1

Cisplatin is a DNA-damaging chemotherapeutic agent used for treating most cancers. Based on cDNA dataset analysis, we investigated how cisplatin modified gene expression and noticed cisplatin-induced dysregulation and system-level variations referring to insulin resistance and sort 2 diabetes mellitus (T2DM). T2DM is a multifactorial illness affecting 462 million individuals on the planet, and drug-induced T2DM is a severe problem.
To perceive this etiology, we designed an integrative, system-level research to determine associations between cisplatin-induced differentially expressed genes (DEGs) and T2DM. From an inventory of differential expressed genes, cisplatin downregulated the cyclin-dependent kinase inhibitor 1 (CDKN1A), tumor necrosis issue (FAS), and sestrin-1 (SESN1) genes chargeable for modifying signaling pathways, together with the p53, JAK-STAT, FOXO, MAPK, mTOR, P13-AKT, Toll-like receptor (TLR), adipocytokine, and insulin signaling pathways. These enriched pathways had been expressively related to the illness.
We noticed important gene signatures, together with SMAD3, IRS, PDK1, PRKAA1, AKT, SOS, RAS, GRB2, MEK1/2, and ERK, interacting with supply genes. This research revealed the worth of system genetics for figuring out the cisplatin-induced genetic variants chargeable for the development of T2DM. Also, by cross-validating gene expression information for T2DM islets, we discovered that downregulating IRS and PRK households is important in insulin and T2DM signaling pathways.
Cisplatin, by inhibiting CDKN1A, FAS, and SESN1, promotes IRS and PRK exercise in the same technique to rosiglitazone (a preferred drug used for T2DM remedy). Our integrative, network-based strategy might help in understanding the drug-induced pathophysiological mechanisms of diabetes.

Relationship between cardiovascular and kidney disease in a sample of patients with diabetes in today’s world

Kidney disease is one of the microvascular complications of diabetes mellitus (DM) with little research and a great relationship with cardiovascular disease (CVD). The objective of this work is to characterize the prevalence of kidney disease in a population of patients with type 2 diabetes who attend outpatient management by cardiology, determine its degree of investigation and its possible effect on the achievement of therapeutic objectives and the use of antidiabetics with cardiorenal protective effect.
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis
Methods: Cross-sectional, observational and multicenter study carried out in 44 centers in Argentina between May and July 2019. Results: 693 patients were included with an established CVD prevalence of 47.5% (329 patients) and 42.3% of microvascular disease . Albuminuria was only assessed in 46.2% of the patients and it was significantly higher in the group with IR. CVD in patients with IR was higher than in those without IR (64.8% vs. 42.2%; p = 0.0001). The presence of albuminuria was accompanied by a higher prevalence of CVD.
The scope of the therapeutic targets was limited and no differences were recognized as a function of RI, with the exception of the LDL target. Low prescription of antidiabetic drugs with proven cardiorenal benefit was observed. Conclusions: The work highlights the importance of the active search for kidney disease in patients with diabetes, which reveals the low scope of therapeutic goals and the prescription of antidiabetic drugs with cardiorenal benefit.

Evaluation of affiliation research and a scientific evaluation and meta-analysis of VDR polymorphisms in sort 2 diabetes mellitus threat

Numerous unique research and four revealed meta-analyses have reported the affiliation between the Vitamin D receptor (VDR) BsmI, FokI, ApaI, and TaqI polymorphisms and sort 2 diabetes mellitus (T2DM) threat. However, the outcomes had been inconsistent.
Therefore, an up to date meta-analysis was carried out to additional discover these points.To additional discover the affiliation between the VDR BsmI, FokI, ApaI, and TaqI polymorphisms and T2DM threat.PubMed, EMBASE, Scopus, and Wanfang databases had been searched. The following search technique had been used: (VDR OR vitamin D receptor) AND (polymorphism OR variant OR mutation) AND (diabetes OR mellitus OR diabetes mellitus).
Pooled crude odds ratios with 95% confidence intervals had been utilized to guage the energy of affiliation in 5 genetic fashions. Statistical heterogeneity, the take a look at of publication bias, and sensitivity analysis had been carried out utilizing the STATA software program (Version 12.0). To consider the credibility of statistically important associations, we utilized the false-positive report chances (FPRP) and Bayesian false discovery chance (BFDP) take a look at.
Overall, the VDR BsmI polymorphism was related to a considerably decreased T2DM threat in Asians; the VDR FokI polymorphism was related to a considerably decreased T2DM threat in Asians, African international locations, and Asian international locations; the VDR ApaI polymorphism was related to a considerably decreased T2DM threat in Caucasians and North American international locations.On the VDR ApaI polymorphism, a considerably elevated T2DM threat was present in a blended inhabitants.

CXCL1 CRISPR Knock Out L3.6pl Cell Line

T6221 ABM 1x10^6 cells / 1.0 ml Ask for price

Ccl2 CRISPR Knock Out CT26 Cell Line

T9611 ABM 1x10^6 cells / 1.0 ml Ask for price

SIRT CRISPR Knock Out Human HepG2 Cell Line - Clone T3-6

T6804 ABM 1x10^6 cells / 1.0 ml Ask for price

PRSS21 CRISPR Knock Out Human OVCAR8 Cell Line - Clone T2 C8

T6811 ABM 1x10^6 cells / 1.0 ml Ask for price

mAdrb2 CRISPR Knock Out B16 Cell Line (T1-10)

T9775 ABM 1x10^6 cells / 1.0 ml Ask for price

PTPN6 CRISPR Knock Out Human THP-1 Cell Line - Clone T3-1

T6813 ABM 1x10^6 cells / 1.0 ml Ask for price

NR2F6 CRISPR Knock Out Human Jurkat E6.1 Cell Line - Clone T3-10

T6822 ABM 1x10^6 cells / 1.0 ml Ask for price

NUAK2 CRISPR Knock Out 293T Cell Line - Clone T3 #41

T6801 ABM 1x10^6 cells / 1.0 ml Ask for price

HeLa/GFP Cell Line

AKR-213 Cell Biolabs 1 vial 388 EUR
Description: Fluorescence

HeLa/Cas9 Cell Line

AKR-5111 Cell Biolabs 1 vial 460 EUR

Aldh2 CRISPR Knock Out L929 Cell Line - Clone T3-20

T9692 ABM 1x10^6 cells / 1.0 ml Ask for price

hPIM1 CRISPR Knock Out SACC-83 Cell Line-T3-9

T9787 ABM 1x10^6 cells / 1.0 ml Ask for price

Dcx CRISPR Knock Out C6 Cell Line (Rat) - Clone sg4-1

T9624 ABM 1x10^6 cells / 1.0 ml 3950 EUR

GLT1 CRISPR Knock Out Rat AST Cell Line - Clone T2-1

T9678 ABM 1x10^6 cells / 1.0 ml Ask for price

PTPN11 CRISPR Knock Out NIH/3T3 Cell Line - Clone T4-9

T6803 ABM 1x10^6 cells / 1.0 ml Ask for price

METTL3 CRISPR Knock Out Caki-1 Cell Line - Clone T2-16

T9623 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Nacc1 CRISPR Knock Out ID8 Cell Line (Mouse) - Clone T1-23

T9627 ABM 1x10^6 cells / 1.0 ml Ask for price

DJ-1 CRISPR Stable Knockout HeLa Cell Line

T6181 ABM 1x10^6 cells / 1.0 ml 3950 EUR

osbpl2 CRISPR Knock Out NIH/3T3 Cell Line - T1 Polyclonal Pool

T9682 ABM 1x10^6 cells / 1.0 ml Ask for price

LIMD1-/- CRISPR Stable Knockout HeLa Cell Line

T6357 ABM 1x10^6 cells / 1.0 ml 3950 EUR

CARMIL1 CRISPR Knock Out Immortalized Human Gingival Fibroblast - hTERT Cell Line - T1-2

T6825 ABM 1x10^6 cells / 1.0 ml Ask for price

Aifm1 CRISPR Knock Out Mouse L929 Cell Line - Clone T2-15-3

T9674 ABM 1x10^6 cells / 1.0 ml Ask for price

SEC61G CRISPR Knock Out HCC-LM3 Cell Line - Clone T2-17-5

T9746 ABM 1x10^6 cells / 1.0 ml Ask for price

Human RRAD knockout cell line

ABC-KH13200 AcceGen 1 vial Ask for price
Description: Human RRAD knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human RRAD knockdown cell line

ABC-KD13200 AcceGen 1 vial Ask for price
Description: Human RRAD knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Cell line gene knock-in and knock-out

S301 101Bio - 15000 EUR

SIRT7 Stable Knockdown HeLa Cell Line

T6164 ABM 1x10^6 cells / 1.0 ml 3950 EUR

RanBPM ShRNA Stable Knockout HeLa Cell Line

T6313 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T3-3

T9529 ABM 1x10^6 cells/1.0ml 3950 EUR

Araf CRISPR Knocked out RAW264.7 Stable cell Cell Line (Mouse) T1-19

T9511 ABM 1x10^6 cells / 1.0 ml 3950 EUR

MAPRE1 Doxycycline Inducible Knockout HeLa Cell Line

T6173 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Stable Mouse Myeloid-derived Suppressor-like LAL Knock Out (HD1B) Cell Line

T3187 ABM 1x10^6 cells / 1.0 ml 3950 EUR

MAPRE1/MAPRE3 Doxycycline Inducible Double Knockout HeLa Cell Line

T6174 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Hela Cell Line

CL-0101 Elabscience Biotech 1×10⁶ cells/vial 420 EUR
Description: Homo sapiens, Human

HeLa Cell Lysate (Human epithelial Cell Line)

LF-R0001 Abfrontier 200 ul 103.2 EUR
Description: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate

HeLa Cell Line (Human cervical carcinoma)

116008 Antibody Research Corporation 1 Vial Ask for price

HeLa Cell Line (Human cervical carcinoma)

116008L Antibody Research Corporation 0.5 mg Ask for price

HeLa Cell Line (Human cervical carcinoma)

116008R Antibody Research Corporation 100 µg Ask for price

cDNA - Human Tumor Cell Line: Hela

C1255811 Biochain 40 reactions 311.5 EUR

Human HRE Reporter Cell Line–HeLa

ABC-RC0095 AcceGen 1 vial Ask for price
Description: Human HRE Reporter Cell Line is derived from HeLa cell. Gentaur can provide high quality reporter cell line for monitoring biological activity

Hela 229 cell line

CL-0634 Elabscience Biotech 1×10⁶ cells/vial 500 EUR
Description: Homo sapiens, human

Human NIS Stable Expressing HeLa Cell Line

T6491 ABM 1x10^6 cells / 1.0 ml Ask for price

Human ATF6 Reporter Cell Line–HeLa

ABC-RC0080 AcceGen 1 vial Ask for price
Description: Human ATF6 Reporter Cell Line is derived from HeLa cells. It can be used for monitoring biological activity

Human ACE2 Stable Expressing HeLa Cell Line

T6044 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Hela S3 cell line

CL-0350 Elabscience Biotech 1×10⁶ cells/vial 500 EUR
Description: Homo sapiens, human

BRCA1 CRISPR Stable Knockout Human Fibroblast Cell Line

T6245 ABM 1x10^6 cells / 1.0 ml 3950 EUR

PTPRA CRISPR Knockout Immortalized Human Lung Fibroblast Cell Line

T6827 ABM 1x10^6 cells / 1.0 ml Ask for price

H2O2 stimulated HeLa Cell Lysate (Human epithelial cell line)

LF-R0002 Abfrontier Each 100 ul 145.2 EUR
Description: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate - H2O2 stimulated

Genomic DNA - Human Tumor Cell Line: Hela

D1255811 Biochain 100 ug 207.2 EUR

HeLa/GFP Cell Line

MBS168642-1Vial MyBiosource 1Vial 650 EUR

HeLa/GFP Cell Line

MBS168642-5x1Vial MyBiosource 5x1Vial 2675 EUR

Human p53 Luciferase Reporter Cell Line- HeLa

ABC-RC0037 AcceGen 1 vial Ask for price
Description: Human p53 Luciferase Reporter Cell Line- HeLa is derived from human cervical cancer, and stably express firefly luciferase reporter gene under the control of the p53 response element. This cell line is an ideal cellular model for monitoring the activation of p53 Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

Human NFAT Luciferase Reporter Cell Line- HeLa

ABC-RC0023 AcceGen 1 vial Ask for price
Description: Human NFAT Luciferase Reporter Cell Line- HeLa is derived from human cervical cancer, and stably express firefly luciferase reporter gene under the control of NFAT response element. This cell line is an ideal cellular model for monitoring the activation of Calcium Signaling Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

ATF6 Reporter HeLa Cell Line

MBS668848-1Vial MyBiosource 1Vial 1960 EUR

ATF6 Reporter HeLa Cell Line

MBS668848-5x1Vial MyBiosource 5x1Vial 8630 EUR

HRE Leeporter HeLa Cell Line

MBS668854-1Vial MyBiosource 1Vial 1960 EUR

HRE Leeporter HeLa Cell Line

MBS668854-5x1Vial MyBiosource 5x1Vial 8630 EUR

p53 Leeporter HeLa Cell Line

MBS668869-1Vial MyBiosource 1Vial 1960 EUR

p53 Leeporter HeLa Cell Line

MBS668869-5x1Vial MyBiosource 5x1Vial 8630 EUR

Human CRISP1 knockout cell line

ABC-KH3569 AcceGen 1 vial Ask for price
Description: Human CRISP1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human CRISP2 knockout cell line

ABC-KH3570 AcceGen 1 vial Ask for price
Description: Human CRISP2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human CRISP3 knockout cell line

ABC-KH3571 AcceGen 1 vial Ask for price
Description: Human CRISP3 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

GCaMP6s Stable HeLa Cell Line

T6483 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Human Stat1 Luciferase Reporter Cell Line- Hela

ABC-RC0040 AcceGen 1 vial Ask for price
Description: Human Stat1 Luciferase Reporter Cell Line- Hela is derived from human cervical cancer,and stably express firefly luciferase reporter gene under the control of the STAT1 response element. This cell line is an ideal cellular model for monitoring the activation of JAK-STAT Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

Human Stat3 Luciferase Reporter Cell Line- Hela

ABC-RC0041 AcceGen 1 vial Ask for price
Description: Human Stat3 Luciferase Reporter Cell Line- Hela is derived from human cervical cancer, and stably express firefly luciferase reporter gene under the control of the STAT3 response element. This cell line is an ideal cellular model for monitoring the activation of JAK-STAT Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

STAT1 Leeporter HeLa Cell Line

MBS668877-1Vial MyBiosource 1Vial 4615 EUR

STAT1 Leeporter HeLa Cell Line

MBS668877-5x1Vial MyBiosource 5x1Vial 20580 EUR

Cas9 Expressing HeLa Cell Line

T3254 ABM 1x10^6 cells / 1.0 ml 795 EUR

293AD Cell Line

AD-100 Cell Biolabs 1 vial 308 EUR
Description: N/A

293AAV Cell Line

AAV-100 Cell Biolabs 1 vial 340 EUR
Description: N/A

293LTV Cell Line

LTV-100 Cell Biolabs 1 vial 340 EUR
Description: N/A

293RTV Cell Line

RV-100 Cell Biolabs 1 vial 340 EUR

Human TLR4/IL-8 Reporter Cell Line– HeLa

ABC-RC0131 AcceGen 1 vial Ask for price
Description: Human TLR4/IL-8 Reporter Cell Line is derived from HeLa. This reporter cell line is an ideal product to monitor the blogical ativity

Human CRISPLD1 knockout cell line

ABC-KH3572 AcceGen 1 vial Ask for price
Description: Human CRISPLD1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human CRISPLD2 knockout cell line

ABC-KH3573 AcceGen 1 vial Ask for price
Description: Human CRISPLD2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human CRISP1 knockdown cell line

ABC-KD3569 AcceGen 1 vial Ask for price
Description: Human CRISP1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human CRISP2 knockdown cell line

ABC-KD3570 AcceGen 1 vial Ask for price
Description: Human CRISP2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human CRISP3 knockdown cell line

ABC-KD3571 AcceGen 1 vial Ask for price
Description: Human CRISP3 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

PTPN6 Stable Knocked Out THP-1 Cell Line

T6216 ABM 1x10^6 cells / 1.0 ml 3950 EUR

293/GFP Cell Line

AKR-200 Cell Biolabs 1 vial 388 EUR
Description: Fluorescence

T47D/GFP Cell Line

AKR-208 Cell Biolabs 1 vial 686.4 EUR
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line.

A549/GFP Cell Line

AKR-209 Cell Biolabs 1 vial 388 EUR
Description: Fluorescence

293/Cas9 Cell Line

AKR-5110 Cell Biolabs 1 vial 460 EUR

NIH3T3/GFP Cell Line

AKR-214 Cell Biolabs 1 vial 388 EUR
Description: Fluorescence

NIH3T3/Cas9 Cell Line

AKR-5104 Cell Biolabs 1 vial 460 EUR

Human TCF/LEF Luciferase Reporter Cell Line- HeLa

ABC-RC0043 AcceGen 1 vial Ask for price
Description: Human TCF/LEF Luciferase Reporter Cell Line- HeLa is derived from human cervical cancer, and stably express firefly luciferase reporter gene under the control of TCF/LEF response element. This cell line is an ideal cellular model for monitoring the activation of Wnt/b-catenin Signaling Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

Fat-1 Stable HeLa Cell Line

T6260 ABM 1x10^6 cells / 1.0 ml 3950 EUR

NFAT-GFP Stable HeLa Cell Line

T6484 ABM 1x10^6 cells / 1.0 ml 3950 EUR

GFP/HeLa Stable Cell Line

MBS669606-1Vial MyBiosource 1Vial 2850 EUR

GFP/HeLa Stable Cell Line

MBS669606-5x1Vial MyBiosource 5x1Vial 12650 EUR

RRAD sgRNA CRISPR Lentivector set (Human)

K2069901 ABM 3 x 1.0 ug 406.8 EUR

Human CRISPLD1 knockdown cell line

ABC-KD3572 AcceGen 1 vial Ask for price
Description: Human CRISPLD1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human CRISPLD2 knockdown cell line

ABC-KD3573 AcceGen 1 vial Ask for price
Description: Human CRISPLD2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

UBG76V-GFP Stable HeLa Cell Line

T6273 ABM 1x10^6 cells / 1.0 ml 3950 EUR

MCF-7/Luc Cell Line

AKR-234 Cell Biolabs 1 vial 686.4 EUR
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.

SKOV-3/Luc Cell Line

AKR-232 Cell Biolabs 1 vial 686.4 EUR
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.

OVCAR-5/RFP Cell Line

AKR-254 Cell Biolabs 1 vial 686.4 EUR
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line.

SIRT7 Stable Scramble HeLa Cell Line

T6258 ABM 1x10^6 cells / 1.0 ml 3950 EUR

RFP Stably Expressing Hela Cell Line 

T3945 ABM 1x10^6 cells / 1.0 ml 1450 EUR

GFP Stably Expressing Hela Cell Line

T3903 ABM 1x10^6 cells / 1.0 ml 1450 EUR

GFAT1 CRISPR Stable Knockout H1299 Cell Line

T6199 ABM 1x10^6 cells / 1.0 ml 3950 EUR

TARGATT? Knock-in Mouse Cell Line Generation Kit (Master Cell Line)

AST-7001 Applied StemCell 1 Kit Ask for price
Description: 6 month

Human RRAS knockout cell line

ABC-KH13205 AcceGen 1 vial Ask for price
Description: Human RRAS knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

EDC4 CRISPR Stable Knockout HEK293T Cell Line

T6241 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Human RRAGA knockout cell line

ABC-KH13201 AcceGen 1 vial Ask for price
Description: Human RRAGA knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human RRAGB knockout cell line

ABC-KH13202 AcceGen 1 vial Ask for price
Description: Human RRAGB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human RRAGC knockout cell line

ABC-KH13203 AcceGen 1 vial Ask for price
Description: Human RRAGC knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human RRAGD knockout cell line

ABC-KH13204 AcceGen 1 vial Ask for price
Description: Human RRAGD knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human RRAS2 knockout cell line

ABC-KH13206 AcceGen 1 vial Ask for price
Description: Human RRAS2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

PDPN CRISPR Stable Knockout COS-7 Cell Line

T6039 ABM 1x10^6 cells / 1.0 ml 3950 EUR

PD-L1 CRISPR Stable Knockout MC38 Cell Line

T6149 ABM 1x10^6 cells / 1.0 ml 3950 EUR

PD-L1 CRISPR Stable Knockout CT26 Cell Line

T6237 ABM 1x10^6 cells / 1.0 ml 3950 EUR

PLN Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF)

iPS41 ALSTEM 1 Vial 2268 EUR

RRAD 3'UTR GFP Stable Cell Line

TU072380 ABM 1.0 ml 1672.8 EUR

Rrad 3'UTR GFP Stable Cell Line

TU269725 ABM 1.0 ml Ask for price

Rrad 3'UTR GFP Stable Cell Line

TU168183 ABM 1.0 ml Ask for price

LRP1 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF)

iPS31 ALSTEM 1 Vial 2268 EUR

AFF2 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF)

iPS61 ALSTEM 1 Vial 2268 EUR

ABCA7 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF)

iPS21 ALSTEM 1 Vial 2268 EUR

KCNK3 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF)

iPS51 ALSTEM 1 Vial 2268 EUR

LLGL1 Knock-out Human Induced Pluripotent Stem Cells (Episomal, HFF)

iPS71 ALSTEM 1 Vial 2268 EUR

Human INF-a/ISRE Luciferase Reporter Cell Line- HeLa

ABC-RC0019 AcceGen 1 vial Ask for price
Description: Human INF-a/ISRE Luciferase Reporter Cell Line- HeLa is derived human cervical cancer, and stably express firefly luciferase reporter gene under the control of IFN-α/ISRE response element. This cell line is an ideal cellular model for monitoring the activation of TYK2 and JAK1 response Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

SLC35A1 CRISPR Stable Knockout CHO-S Cell Line

T6040 ABM 1x10^6 cells / 1.0 ml 3950 EUR

CXCL1 & CXCL8 CRISPR Double Knockout L3.6pl Cell Line

T6047 ABM 1x10^6 cells / 1.0 ml Ask for price

Human RRAS knockdown cell line

ABC-KD13205 AcceGen 1 vial Ask for price
Description: Human RRAS knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

TARGATT? Knock-in iPSC Generation (Master Cell Line)

AST-1100 Applied StemCell 1 vial of 1X10^6 cells Ask for price
Description: 6 month

TLR4/IL-8 Leeporter HeLa Cell Line

MBS668887-1Vial MyBiosource 1Vial 6535 EUR

TLR4/IL-8 Leeporter HeLa Cell Line

MBS668887-5x1Vial MyBiosource 5x1Vial 29220 EUR

Human RRAGA knockdown cell line

ABC-KD13201 AcceGen 1 vial Ask for price
Description: Human RRAGA knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human RRAGB knockdown cell line

ABC-KD13202 AcceGen 1 vial Ask for price
Description: Human RRAGB knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human RRAGC knockdown cell line

ABC-KD13203 AcceGen 1 vial Ask for price
Description: Human RRAGC knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human RRAGD knockdown cell line

ABC-KD13204 AcceGen 1 vial Ask for price
Description: Human RRAGD knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human RRAS2 knockdown cell line

ABC-KD13206 AcceGen 1 vial Ask for price
Description: Human RRAS2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

RRAD sgRNA CRISPR Lentivector (Human) (Target 1)

K2069902 ABM 1.0 ug DNA 184.8 EUR

RRAD sgRNA CRISPR Lentivector (Human) (Target 2)

K2069903 ABM 1.0 ug DNA 184.8 EUR

RRAD sgRNA CRISPR Lentivector (Human) (Target 3)

K2069904 ABM 1.0 ug DNA 184.8 EUR

Hela / Cas9 (Bad) Stable Cell Line

SC045-Cas9-Bsd GenTarget 2 x 106 cell/ml x 1ml 1269.6 EUR
Description: Cas9 expression stable cell line with Blasticidin resistance in Hela human cervical cancer cells.

AXL CRISPR Stable Knockout HT1080 (1-IV) Cell Line

T6232 ABM 1x10^6 cells / 1.0 ml 3950 EUR

AXL CRISPR Stable Knockout HT1080 (3-II) Cell Line

T6233 ABM 1x10^6 cells / 1.0 ml 3950 EUR

Rrad 3'UTR Luciferase Stable Cell Line

TU118183 ABM 1.0 ml Ask for price

Rrad 3'UTR Luciferase Stable Cell Line

TU219725 ABM 1.0 ml Ask for price

RRAD 3'UTR Luciferase Stable Cell Line

TU022380 ABM 1.0 ml 1672.8 EUR

Whale NIS Stable Expressing HeLa Cell Line

T6492 ABM 1x10^6 cells / 1.0 ml Ask for price

Zebra NIS Stable Expressing HeLa Cell Line

T6493 ABM 1x10^6 cells / 1.0 ml Ask for price

Inducible GFP Hela stable cell line

SC036 GenTarget 2 x 106 cell/ml x 1ml 1800 EUR
Description: InducibleGFP expression stable cell line in Hela cells, with Neomycin and puromycin resitance

Inducible RFP Hela stable cell line

SC037 GenTarget 2 x 106 cell/ml x 1ml 1800 EUR
Description: Inducible RFP expression stable cell line in Hela with Blasticidin and Puromycin resistance

Human HELB knockout cell line

ABC-KH6684 AcceGen 1 vial Ask for price
Description: Human HELB knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human HELQ knockout cell line

ABC-KH6686 AcceGen 1 vial Ask for price
Description: Human HELQ knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human HELT knockout cell line

ABC-KH6687 AcceGen 1 vial Ask for price
Description: Human HELT knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human HELZ knockout cell line

ABC-KH6688 AcceGen 1 vial Ask for price
Description: Human HELZ knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.
×
However, once we additional carried out a sensitivity analysis, FPRP, and BFDP take a look at, less-credible optimistic outcomes had been recognized (all FPRP > 0.2 and BFDP > 0.8) in any important affiliation.In abstract, this research strongly signifies that every one important associations had been much less credible optimistic outcomes, fairly than from true associations.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Capilia Rapid Antigen
  • Compare Appoptosis lab reagents for research
  • Compare ELISA lab reagents for research
  • Treating Diabetes Utilizing a Low Carbohydrate Ketogenic Diet and Intermittent Fasting Without Significant Weight Loss: A Case Report
  • Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis

Distributors

Europe Gentaur group

Archives

  • October 2023
  • December 2022
  • September 2021
  • August 2021
  • July 2021
  • October 2020
  • May 2020
  • February 2020

Categories

  • blood
  • Blot
  • cDNA
  • ChiP
  • coli recombinant
  • colorimetric
  • Control
  • dna
  • Effects of Laser Acupuncture and Dietary Intervention on Key Obesity Parameters.
  • elektroporation
  • elisa
  • Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
  • Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes.
  • protein
  • Rabbit
  • Rat
  • rna
  • Salmonella
  • Sheep
  • step
  • sterile
  • The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting.
  • The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak.
  • Torpedo
  • Trout
  • Yeast
  • blood
  • Blot
  • cDNA
  • ChiP
  • coli recombinant
  • colorimetric
  • Control
  • dna
  • Effects of Laser Acupuncture and Dietary Intervention on Key Obesity Parameters.
  • elektroporation
  • elisa
  • Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
  • Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes.
  • protein
  • Rabbit
  • Rat
  • rna
  • Salmonella
  • Sheep
  • step
  • sterile
  • The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting.
  • The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak.
  • Torpedo
  • Trout
  • Yeast
  • Capilia Rapid Antigen
  • Compare Appoptosis lab reagents for research
  • Compare ELISA lab reagents for research
  • Treating Diabetes Utilizing a Low Carbohydrate Ketogenic Diet and Intermittent Fasting Without Significant Weight Loss: A Case Report
  • Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis
© 2026 Prosidion Ltd. | Powered by Superbs Personal Blog theme